A computational bio-chemo-mechanical model of in vivo tissue-engineered vascular graft development
Integrative Biology · 14.04.2020 · 12 (3) · 47-63
DOI: 10.1093/intbio/zyaa004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrative Biology, online erschienen am 28.03.2020. Verfasst von Ramak Khosravi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Yale University, New Haven, CT, USA. Hauptthemen laut MEDLINE: Blood Vessel Prosthesis, Prosthesis Design, Tissue Scaffolds. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Stenosis is the primary complication of current tissue-engineered vascular grafts used in pediatric congenital cardiac surgery. Murine models provide considerable insight into the possible mechanisms underlying this situation, but they are not efficient for identifying optimal changes in scaffold design or therapeutic strategies to prevent narrowing. In contrast, computational modeling promises to enable time- and cost-efficient examinations of factors leading to narrowing. Whereas past models have been limited by their phenomenological basis, we present a new mechanistic model that integrates molecular- and cellular-driven immuno- and mechano-mediated contributions to in vivo neotissue development within implanted polymeric scaffolds. Model parameters are inferred directly from in vivo measurements for an inferior vena cava interposition graft model in the mouse that are augmented by data from the literature. By complementing Bayesian estimation with identifiability analysis and simplex optimization, we found optimal parameter values that match model outputs with experimental targets and quantify variability due to measurement uncertainty. Utility is illustrated by parametrically exploring possible graft narrowing as a function of scaffold pore size, macrophage activity, and the immunomodulatory cytokine transforming growth factor beta 1 (TGF-β1). The model captures salient temporal profiles of infiltrating immune and synthetic cells and associated secretion of cytokines, proteases, and matrix constituents throughout neovessel evolution, and parametric studies suggest that modulating scaffold immunogenicity with early immunomodulatory therapies may reduce graft narrowing without compromising compliance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
- Department of Applied and Computational Mathematics and Statistics, University of Notre Dame, Notre Dame, IN, USA.
- Center for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
- Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT, USA.
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
Zitieren
APA
Khosravi, R., Ramachandra, A. B., Szafron, J. M., Schiavazzi, D. E., Breuer, C. K., & Humphrey, J. D. (2020). A computational bio-chemo-mechanical model of in vivo tissue-engineered vascular graft development. Integrative Biology, 12(3), 47-63. https://doi.org/10.1093/intbio/zyaa004
Vancouver
Khosravi R, Ramachandra AB, Szafron JM, Schiavazzi DE, Breuer CK, Humphrey JD. A computational bio-chemo-mechanical model of in vivo tissue-engineered vascular graft development. Integrative Biology. 2020;12(3):47-63. doi:10.1093/intbio/zyaa004
BibTeX
@article{Khosravi2020,
author = {Khosravi, Ramak and Ramachandra, Abhay B and Szafron, Jason M and Schiavazzi, Daniele E and Breuer, Christopher K and Humphrey, Jay D},
title = {A computational bio-chemo-mechanical model of in vivo tissue-engineered vascular graft development},
journal = {Integrative Biology},
year = {2020},
volume = {12},
number = {3},
pages = {47--63},
doi = {10.1093/intbio/zyaa004}
}
EUVIMED